Whole-exome sequencing of a multicenter cohort identifies genetic changes associated with clinical phenotypes in pediatric nephrotic syndrome
返回论文页
Full-length article|更新时间:2022-11-09
|
Whole-exome sequencing of a multicenter cohort identifies genetic changes associated with clinical phenotypes in pediatric nephrotic syndrome
Whole-exome sequencing of a multicenter cohort identifies genetic changes associated with clinical phenotypes in pediatric nephrotic syndrome
Genes & Diseases2022年9卷第6期
作者机构:
1. Department of Nephrology, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatrics,Chongqing,PR China,400015
2. Department of Nephrology, Chengdu Women and Children Central Hospital,Sichuan,Chengdu,PR China,610091
3. Department of Nephrology, Sheen Children's Hospital,Guangdong,Shenzhen,PR China,518034
Whole-exome sequencing of a multicenter cohort identifies genetic changes associated with clinical phenotypes in pediatric nephrotic syndrome[J]. Genes & Diseases, 2022,9(6).
Jia Jiao, Li Wang, Fenfen Ni, et al. Whole-exome sequencing of a multicenter cohort identifies genetic changes associated with clinical phenotypes in pediatric nephrotic syndrome[J]. Genes & Diseases, 2022,9(6).
Whole-exome sequencing of a multicenter cohort identifies genetic changes associated with clinical phenotypes in pediatric nephrotic syndrome[J]. Genes & Diseases, 2022,9(6). DOI: 10.1016/j.gendis.2022.03.023.
Jia Jiao, Li Wang, Fenfen Ni, et al. Whole-exome sequencing of a multicenter cohort identifies genetic changes associated with clinical phenotypes in pediatric nephrotic syndrome[J]. Genes & Diseases, 2022,9(6). DOI: 10.1016/j.gendis.2022.03.023.
Whole-exome sequencing of a multicenter cohort identifies genetic changes associated with clinical phenotypes in pediatric nephrotic syndrome
摘要
Abstract
Understanding the association between the genetic and clinical phenotypes in children with nephrotic syndrome (NS) of different etiologies is critical for early clinical guidance. We employed whole-exome sequencing (WES) to detect monogenic causes of NS in a multicenter cohort of 637 patients. In this study
a genetic cause was identified in 30.0% of the idiopathic steroid-resistant nephrotic syndrome (SRNS) patients. Other than congenital nephrotic syndrome (CNS)
there were no significant differences in the incidence of monogenic diseases based on the age at manifestation. Causative mutations were detected in 39.5% of patients with focal segmental glomerulosclerosis (FSGS) and 9.2% of those with minimal change disease (MCD). In terms of the patterns in patients with different types of steroid resistance
a single gene mutation was identified in 34.8% of patients with primary resistance
2.9% with secondary resistance
and 71.4% of children with multidrug resistance. Among the various intensified immunosuppressive therapies
tacrolimus (TAC) showed the highest response rate
with 49.7% of idiopathic SRNS patients achieving complete remission. Idiopathic SRNS patients with monogenic disease showed a similar multidrug resistance pattern
and only 31.4% of patients with monogenic disease achieved a partial remission on TAC. During an average 4.1-year follow-up
21.4% of idiopathic SRNS patients with monogenic disease progressed to end-stage renal disease (ESRD). Collectively
this study provides evidence that genetic testing is necessary for presumed steroid-resistant and idiopathic SRNS patients
especially those with primary and/or multidrug resistance.